Adaptive immune responses play critical roles in viral clearance and protection against re‐
infection, and SARS‐CoV‐2 is no exception. What is exceptional is the rapid …

Although SARS‐CoV‐2 vaccines are very safe, we report 4 cases of the bifacial weakness
with paresthesias variant of Guillain–Barré syndrome (GBS) occurring within 3 weeks of …

Introduction As the repercussions from the COVID-19 pandemic continue to unfold, an ever-
expanding body of evidence suggests that infection also elicits pathophysiological …

Studies on the humoral response to homologous BNT162b2 mRNA-vaccination focus
mainly on IgG antibody dynamics, while long-term IgA kinetics are understudied. Herein …

In the COVID-19 pandemic era, antibody testing against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has proven an invaluable tool and herein we highlight some of …

Over 10% of COVID-19 convalescents report post-COVID-19 complications, namely,'long
COVID'or 'post-COVID syndrome,'including a number of neuro-psychiatric symptoms. The …

Abstract Coronavirus disease 2019 (COVID-19), which is caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global public health …

Background and purpose A wide range of neuroradiological findings has been reported in
patients with coronavirus disease 2019 (COVID-19), ranging from subcortical white matter …

Background: Central nervous system (CNS) symptoms may occur in patients with acute
COVID-19. The role of CSF examination in these patients remains to be established …

Introduction Increased levels of extracellular vesicles (EVs) are associated with haemostatic
disturbances in various clinical settings. However, their role in COVID‐19 patients is still not …